Key facts
- It has raised $92.3M across 2 recorded rounds; the latest was Early Stage VC ($9.0M) in Dec 2017.
- Notable investors include BroadOak Capital Partners, Current Yield with Participation Fund, NewVale Capital, Telegraph Hill Partners, The Osterweis Revocable Trust.
- Argonaut Manufacturing Services has filed 2 Form Ds with the SEC since 2016, most recently Dec 2017 ($9.0M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Argonaut Manufacturing Services
Funding rounds
2 roundsAbout Argonaut Manufacturing Services
Operator of a contract manufacturing company intended to supply chain technologies for biopharmaceutical, life science, and molecular diagnostics. The company's services include aseptic fill and finish, reagent formulation, filling, kitting, lyophilization, and analytical support, enabling clients to get various diagnostics and drug products for diverse outsourcing needs.
- Sector
- Business Products and Services (B2B)
- HQ
- Carlsbad, CA, United States
- Founded
- 2016
- Employees
- 104
- Website
- argonautms.com/
- Ownership
- Privately Held (backing)
Argonaut Manufacturing Services doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Argonaut Manufacturing Services shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Argonaut Manufacturing Services in its N-PORT filings yet. We sweep new filings monthly.